View moreSupriya Lifescience Ltd
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Insufficient Data
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Supriya Lifescience Ltd
SUPRIYA
Price Chart
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Insufficient Data
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Key Metrics
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Supriya Lifescience is a manufacturer of pharmaceutical preparation.
Investor PresentationView older
View Older PresentationsPeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Gland Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
See all news
Recent EventsAll events
Investor Presentation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (￢ﾀﾜCompany￢ﾀﾝ) will be interacting with Analyst/Institutional Investors on July 5, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company￢ﾀﾙs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (￢ﾀﾜCompany￢ﾀﾝ) will be interacting with Analyst/Institutional Investors on July 5, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company￢ﾀﾙs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Investor Presentation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (￢ﾀﾜCompany￢ﾀﾝ) will be interacting with Analyst/Institutional Investors on July 1, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company￢ﾀﾙs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (￢ﾀﾜCompany￢ﾀﾝ) will be interacting with Analyst/Institutional Investors on July 1, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company￢ﾀﾙs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Investor Presentation
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (￢ﾀﾜCompany￢ﾀﾝ) will be interacting with Analyst/Institutional Investors on June 30, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company￢ﾀﾙs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (￢ﾀﾜCompany￢ﾀﾝ) will be interacting with Analyst/Institutional Investors on June 30, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company￢ﾀﾙs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value